Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
You could win a cash prize of up to £25,000 when you play the Breakthrough T1D lottery. As well as the chance to win great prizes, you’ll also help fund our research to find a cure for type 1 diabetes.
Researchers need your help. By taking part in research studies and clinical trials, you will help them make progress to improve lives and find a cure for type 1 diabetes.
Our ambitious new roadmap is aimed at driving significant advancements in type 1 diabetes research, treatment, and care.
Your donation helps support people living with type 1 diabetes and funds the best treatment and cure research.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
Home > Connect Immune Research Support Volunteer
Breakthrough T1D is a founding member of Connect Immune Research, a partnership of 17 charities and organisations with a shared interest in autoimmunity and autoimmune conditions. As the partnership’s secretariat, Breakthrough T1D coordinates meetings, supports partnership activities, and facilitates communication between member organisations to ensure effective collaboration.
The Breakthrough T1D Research Partnerships Team is seeking a volunteer to support the coordination of monthly communications across the Connect Immune Research partnership. This role will help keep partners informed, engaged, and connected by contributing to the development and distribution of regular partnership updates.
We ask for a commitment of at least one hour per week, with the role starting as soon as possible. The exact time commitment can be discussed during the application process, and we’re flexible in recognising that volunteering needs to fit around your existing commitments.
This is an ongoing opportunity to support the Connect Immune Research partnership by helping to identify and share relevant research news, publications, events, and other updates on a rolling monthly basis.
Remotely, with the option to work in Breakthrough T1D’s head office in central London.
Please email your CV and cover letter, briefly explaining why you wish to fill this role, to Sarah Berry (Research Partnerships Manager) on connect@breakthrought1d.org.uk.
Please note: For this role, you must be based in the UK. You will also need access to your own laptop and the internet.
Connect Immune Research is a partnership between 17 UK-based charities and organisations who want to understand how immune conditions are linked. We want the scientific community to work together across autoimmunity specialisms to tackle multiple conditions at once. Understanding similarities and using existing knowledge of different conditions could help transform lives much faster than small groups of specialists working on separate conditions.
Monthly email updates for member charities help keep partners informed about developments both within and beyond the partnership. They provide updates on emerging trends, relevant publications, and key activities, fostering a well-informed, connected, and collaborative partnership community.
The BSI journal of ‘Clinical & Experimental Immunology‘ has launched a new Immunometabolism section, which welcomes submissions spanning fundamental, translational and clinical research, with a focus on studies that deepen our understanding of the complex interactions between metabolism and immunity. Read the article to find out more
Alopecia UK has published a Summer Research Update, which provides an overview of research activity in alopecia. Updates include the role of the microbiota in alopecia, and latest developments in immune-targeting therapies, including dupilumab (targeting IL‑4 and IL‑13), HCW9302 (an IL‑2-containing therapy), bempikibart (targeting IL‑7), and amlitelimab (which blocks OX40L, a molecule involved in T-cell activation).
The British Thyroid Foundation are leading a JLA PSP for thyroid disease, including autoimmune thyroid disease, to help shape the future of thyroid research in the UK. As part of this process, they are inviting people to complete an online survey to highlight what areas they want thyroid research to focus on. More information is available on the BTF and JLA webpages.
Would you like to visit the website of our {{ affiliate_country }} affiliate to complete your action?